Nifty Pharma 22011.7 (-3.33)
Nifty Smallcap 100 17668.2 (-1.66)
Nifty 50 24565.35 (-0.82)
Nifty IT 34649.6 (-1.85)
Nifty Midcap 100 56637.15 (-1.33)
SENSEX 80599.91 (-0.72)
Nifty Next 50 66192.8 (-1.35)
Nifty Bank 55617.6 (-0.62)
NIKKEI 225 40799.6 (-0.66)
HANG SENG 24507.81 (-1.07)
S&P 6275.25 (-1.74)
31-Oct-2024
Sales up 41%, but growth at net restricted at 7%
'Standalone net sales (including other operating income) of Railtel Corporation of India for the quarter ended Sep 2024 has increased 40.78% to Rs 843.49 crore. Operating profit margin has declined from 21.27% to 15.33%, leading to 1.49% rise in operating profit to Rs 129.32 crore. Lower OPM is largely due to increased contribution to revenue from low margin projects business. Employee cost decreased from 8.61% to 6.31%. Other expenses rose from 70.12% to 78.36%. Selling and administration expenses fell from 20.65% to 16.48%. Other direct service cost rose from 48.06% to 60.62%.
Other income up 39.14% to Rs 19.02 crore. PBIDT rose 5.14% to Rs 148.34 crore. Provision for interest fell 9.84% to Rs 0.55 crore. PBDT rose 5.20% to Rs 147.79 crore. Provision for depreciation rose 5.31% to Rs 39.88 crore. Profit before tax grew 5.17% to Rs 107.91 crore. Extra...
(01-Aug-2025)
Sales up 2%, net down 3%
Net up 34% on higher sales
Sales up 23%, net down 9% as OPM down by 410 bps
AUM rises 24%, disbursements up 15% for Q1FY2026
Analyst Meet / AGM-Conference Call (30-Jul-2025)
Expect a revenue growth of about 25% for FY26
Results-Analysis (29-Jul-2025)
Net up 36% driven largely by higher sales
Analyst Meet / AGM-Conference Call (06-May-2025)
Expect a revenue growth of 25-30% for FY26.
Results-Analysis (02-May-2025)
Net up 46% on higher sales